3 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow moshe yeshurun: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. N acetyl cysteine - Mucositis, Transplant-Related Disorder | Phase 3 | Unknown | moshe yeshurun | 116 | 2021-04-01 | 2021-02-16 |
| Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease Cannabidiol, Methylprednisolone, Calcineurin inhibitor - Acute-graft-versus-host Disease | Phase 2 | Unknown | moshe yeshurun | 10 | 2015-04-01 | 2015-03-19 |
| Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation eltrombopag - Pediatric Patients Undergoing Allogeneic Cord Blood Transplantation. | Phase 2 | Unknown | moshe yeshurun | 20 | 2013-10-01 | 2015-06-16 |
Mucositis (1)
Acetylcysteine (1) · Calcineurin Inhibitors (1) · Cannabidiol (1) · Methylprednisolone (1) · eltrombopag (1)
Israel (2)